Follow
Jake Lever
Title
Cited by
Cited by
Year
Points of significance: Principal component analysis
J Lever, M Krzywinski, N Altman
Nature methods 14 (7), 641-643, 2017
12872017
Points of significance: Model selection and overfitting
J Lever, M Krzywinski, N Altman
Nature Methods 13 (9), 703, 2016
5972016
Points of significance: Classification evaluation
J Lever, M Krzywinski, N Altman
Nature methods 13 (8), 603-604, 2016
366*2016
CancerMine: a literature-mined resource for drivers, oncogenes and tumor suppressors in cancer
J Lever, EY Zhao, J Grewal, MR Jones, SJM Jones
Nature methods 16 (6), 505-507, 2019
1492019
Points of significance: Logistic regression
J Lever, M Krzywinski, N Altman
Nature Methods 13 (7), 541-542, 2016
113*2016
Identification and analyses of extra-cranial and cranial rhabdoid tumor molecular subgroups reveal tumors with cytotoxic T cell infiltration
HJE Chun, PD Johann, K Milne, M Zapatka, A Buellesbach, N Ishaque, ...
Cell reports 29 (8), 2338-2354. e7, 2019
822019
Points of significance: Regularization
J Lever, M Krzywinski, N Altman
Nature methods 13 (10), 803-804, 2016
512016
Small molecule epigenetic screen identifies novel EZH2 and HDAC inhibitors that target glioblastoma brain tumor-initiating cells
N Grinshtein, CC Rioseco, R Marcellus, D Uehling, A Aman, X Lun, ...
Oncotarget 7 (37), 59360, 2016
492016
Comparative genomic and genetic analysis of glioblastoma-derived brain tumor-initiating cells and their parent tumors
B Davis, Terry Fox Research Institute Glioblastoma Consortium, Y Shen, ...
Neuro-oncology 18 (3), 350-360, 2015
482015
Comprehensive genomic profiling of glioblastoma tumors, BTICs, and xenografts reveals stability and adaptation to growth environments
Y Shen, CJ Grisdale, SA Islam, P Bose, J Lever, EY Zhao, N Grinshtein, ...
Proceedings of the National Academy of Sciences 116 (38), 19098-19108, 2019
472019
VERSE: Event and relation extraction in the BioNLP 2016 Shared Task
J Lever, SJM Jones
Proceedings of the 4th BioNLP shared task workshop, 42-49, 2016
392016
Text-mining clinically relevant cancer biomarkers for curation into the CIViC database
J Lever, MR Jones, AM Danos, K Krysiak, M Bonakdar, JK Grewal, ...
Genome medicine 11, 1-16, 2019
372019
Analyzing the vast coronavirus literature with CoronaCentral
J Lever, RB Altman
Proceedings of the National Academy of Sciences 118 (23), e2100766118, 2021
332021
A collaborative filtering-based approach to biomedical knowledge discovery
J Lever, S Gakkhar, M Gottlieb, T Rashnavadi, S Lin, C Siu, M Smith, ...
Bioinformatics 34 (4), 652-659, 2018
302018
LIONS: analysis suite for detecting and quantifying transposable element initiated transcription from RNA-seq
A Babaian, IR Thompson, J Lever, L Gagnier, MM Karimi, DL Mager
Bioinformatics 35 (19), 3839-3841, 2019
272019
Painless relation extraction with kindred
J Lever, SJM Jones
BioNLP 2017, 176-183, 2017
172017
PGxMine: text mining for curation of PharmGKB
J Lever, JM Barbarino, L Gong, R Huddart, K Sangkuhl, R Whaley, ...
PACIFIC SYMPOSIUM ON BIOCOMPUTING 2020, 611-622, 2019
142019
CIViCdb 2022: evolution of an open-access cancer variant interpretation knowledgebase
K Krysiak, AM Danos, J Saliba, JF McMichael, AC Coffman, S Kiwala, ...
Nucleic acids research 51 (D1), D1230-D1241, 2023
112023
Real-time controllable fire using textured forces
J Lever, T Komura
The Visual Computer, 1-10, 2012
112012
Correction: Corrigendum: Classification evaluation
J Lever, M Krzywinski, N Altman
Nature Methods 13 (10), 890-890, 2016
72016
The system can't perform the operation now. Try again later.
Articles 1–20